Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06517225 · ClinicalTrials.gov registry record · Phase 2

Visual-acoustic Intervention With Service Delivery In-person and Via Telepractice Trial

A Phase 2 study of Speech Sound Disorder, sponsored by New York University.

Recruiting
Registry status
Phase 2
Development phase
76
Enrollment target
3
Study locations

NCT06517225: Recruiting Phase 2 study of Speech Sound Disorder, sponsored by New York University.

NCT06517225 is a Phase 2 study of Speech Sound Disorder that is actively recruiting participants, run by New York University. The registered enrollment target is 76 participants, below the 84-participant average among 15 other Speech Sound Disorder trials with a reported enrollment target (10% lower). The trial reports 3 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06517225, a Phase 2 study of Speech Sound Disorder, is actively recruiting participants, sponsored by New York University.

RECRUITING
Registry status
Phase 2
Development phase
76 participants
Enrollment target
3
Study locations

Study Summary

Children with speech sound disorder show diminished intelligibility in spoken communication and may thus be perceived as less capable than peers, with negative consequences for both socioemotional and socioeconomic outcomes. New technologies have the potential to transform interventions for speech sound disorder, but there is a lack of rigorous evidence to substantiate this promise. This research will meet a public health need by systematically evaluating the efficacy of visual-acoustic biofeedback intervention delivered in-person versus via telepractice. The objective of this study is to test the hypothesis that treatment incorporating visual-acoustic biofeedback can be delivered via telepractice without a significant loss of efficacy. Participants will be randomly assigned to receive identical treatment either via online telepractice or in the laboratory setting. The same software for visual-acoustic biofeedback, staRt, will be used in both conditions. Participants' progress in treatment will be evaluated based on blinded listeners' perceptual ratings of probes produced before and after treatment. Pre and post treatment evaluations will be carried out in person for all participants.

Primary Outcome

To assess generalization of treatment gains to untreated words, participants will be assessed with standard probes (30 words \[considered the primary target\], 20 syllables, and 10 sentences containing /r/ in various phonetic contexts). Stimuli in each probe will be presented individually in randomized order with blocking by stimulus type (word, syllable, sentence). Individual words will be isolated from the audio record of each word probe and presented in randomized order for binary rating (cor

Conditions Studied

Interventions

  • BEHAVIORAL Visual-acoustic biofeedback

Study Locations (3)

New York

  • New York University - New York
  • Syracuse University - Syracuse

New Jersey

  • Montclair State University - Bloomfield

Trial Details

FieldValue
Enrollment Target 76 participants
Start Date 2024-07-01
Est. Completion 2028-12-31
Phase Phase 2
New York University

83 total trials

What NCT06517225 shows while recruiting

NCT06517225 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 76 participants, a relatively small participant target, below the 84-participant average among 15 other Speech Sound Disorder trials with a reported enrollment target (10% lower).

The record links to 1 condition, with Speech Sound Disorder appearing as the primary indexed condition, and to 1 intervention - of which Visual-acoustic biofeedback is the first listed.

NCT06517225 reports a single indexed study location in New York, New Jersey.

Frequently Asked Questions

What is clinical trial NCT06517225 about?

NCT06517225 is a clinical study titled "Visual-acoustic Intervention With Service Delivery In-person and Via Telepractice Trial". Children with speech sound disorder show diminished intelligibility in spoken communication and may thus be perceived as less capable than peers, with negative consequences for both socioemotional and socioeconomic outcomes. New technologies have the potential to transform interventions for speech s...

What is the current status of trial NCT06517225?

This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 76 participants. The study started on 2024-07-01. Estimated completion is 2028-12-31.

What conditions does trial NCT06517225 study?

This clinical trial studies the following conditions: Speech Sound Disorder.

What interventions are being tested in trial NCT06517225?

The interventions under investigation include: Visual-acoustic biofeedback (BEHAVIORAL).

Who is sponsoring clinical trial NCT06517225?

This trial is sponsored by New York University, which has 83 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06517225 being conducted?

This trial has 3 study locations across New Jersey, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Speech Sound Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06517225's enrollment target sits among peer trials

76 6th of 15 higher than 9 of 15 other Speech Sound Disorder trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Speech Sound Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02615184 · 76 participants · Phase 2

    A Study to Check the Safety of Dexlansoprazole and Learn If it Can Heal Erosive Esophagitis (EE) and Keep it Healed in Children 2 to 11 Years Old

  • NCT02821741 · 76 participants · NA

    Effects of External Ear Stimulation on Pain Perception and Mood

  • NCT03019757 · 76 participants

    Distinguishing Between Alzheimer's Disease, Lewy Body Dementia, and Parkinson's Disease

  • NCT03353584 · 76 participants · NA

    Effect of Virtual Reality Technology for Pain Management of Vaso-Occlusive Crisis in Patients With Sickle Cell Disease

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06517225, the US trial registry maintained by the National Library of Medicine. NCT06517225 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.